# Azstarys Criteria guidance

[Weekly Email 10/28/23](https://mygainwell-my.sharepoint.com/:w:/g/personal/christopher_nguyen_gainwelltechnologies_com/EXJx_sD8orNPtWuRDxSZljkBhvGzfjc5q-8Hlo3nhm6_Wg?e=bdjdYQ){:target="_blank" rel="noopener"}

•	Azstarys – since this is a combo med and some confusion with criteria, ODM has confirmed that ***3 trials of long acting agents is sufficient for approval of this product***.
